Morin et al. (53) reported that the eicosapentaenoic acid monoglyceride (MAG-EPA) treatment increased HCT-116 cell apoptosis and decreased the tumor of a mouse xenograft model of HCT-116 via activating the vascular endothelial growth factor (VEGF) receptor pathway and decreasing the epidermal growth factor receptor (EGFR). Here, EGFR is linked to neoplasm.